1
Clinical Trials associated with Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells(The Children's Hospital of Philadelphia)Phase II Study for Patients With Primary Immunodeficiencies Using and Cd19+ Depleted Unrelated Donor or Partially Matched Related Donor Peripheral Stem Cells
This is a Phase II trial to determine the ability of a reduced intensity conditioning regimen to allow successful engraftment with alpha/beta T and CD19+ depleted peripheral stem cell grafts from unrelated or partially matched related donors. There are two conditioning regimens depending upon patient diagnosis and age.
100 Clinical Results associated with Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells(The Children's Hospital of Philadelphia)
100 Translational Medicine associated with Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells(The Children's Hospital of Philadelphia)
100 Patents (Medical) associated with Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells(The Children's Hospital of Philadelphia)
100 Deals associated with Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells(The Children's Hospital of Philadelphia)